159 related articles for article (PubMed ID: 10195921)
1. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Wilcox LJ; Barrett PH; Huff MW
J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
[TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
[TBL] [Abstract][Full Text] [Related]
7. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
Avramoglu RK; Cianflone K; Sniderman AD
J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
9. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
[TBL] [Abstract][Full Text] [Related]
11. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
Burnett JR; Wilcox LJ; Huff MW
Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
[TBL] [Abstract][Full Text] [Related]
12. Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.
Izem L; Rassart E; Kamate L; Falstrault L; Rhainds D; Brissette L
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):81-9. PubMed ID: 9405278
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
Brown A; Wiggins D; Gibbons GF
Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
18. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
Wilcox LJ; Borradaile NM; de Dreu LE; Huff MW
J Lipid Res; 2001 May; 42(5):725-34. PubMed ID: 11352979
[TBL] [Abstract][Full Text] [Related]
19. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
Carr TP; Hamilton RL; Rudel LL
J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
[TBL] [Abstract][Full Text] [Related]
20. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.
Borradaile NM; de Dreu LE; Wilcox LJ; Edwards JY; Huff MW
Biochem J; 2002 Sep; 366(Pt 2):531-9. PubMed ID: 12030847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
